文献速递肿瘤 PET/CT

基于18F-FDG-PET/CT影像组学分析预测非小细胞肺癌PD-L1表达状态

Predicting PD-L1 expression status in NSCLC using radiomic analysis of 18 F-FDG-PET/CT images.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-07-16

本研究回顾性分析105例不同表型非小细胞肺癌患者的初诊分期18F-FDG-PET/CT图像,采用多种分割技术提取影像组学特征,按7:3分为训练集与测试集,经Mann-Whitney U检验、LASSO回归和Spearman相关分析降维后建立逻辑回归模型。作者认为18F-FDG-PET/CT影像组学特征有潜力无创区分PD-L1阳性与阴性NSCLC。

要点

  • 105例NSCLC患者中腺癌72例、鳞癌33例,PD-L1阳性64例、阴性41例。
  • 模型灵敏度90.00%、阳性预测值81.81%、阴性预测值80.00%。

核心结论

  • 源自18F-FDG-PET/CT图像的影像组学特征有潜力区分PD-L1阳性与阴性的非小细胞肺癌。
  • 影像组学结合多模态影像为筛选可能受益于靶向免疫治疗的患者提供了一种有前景的无创方法。

研究设计与样本

  • 回顾性研究,分析105例不同表型非小细胞肺癌患者的初诊分期18F-FDG-PET/CT扫描,其中腺癌72例、鳞癌33例,PD-L1阳性64例、PD-L1阴性41例。
  • 采用多种分割技术,使用PyRadiomics软件包从原始图像和变换后图像提取影像组学特征。
  • 记录按7:3比例分为训练集与测试集,特征降维采用Mann-Whitney U检验、LASSO回归和Spearman相关分析,基于所选特征建立逻辑回归模型,并以ROC曲线、AUC评分等指标评估性能。

主要发现

  • 最优模型准确率为81.25%。
  • 最优模型灵敏度为90.00%,阳性预测值为81.81%,阴性预测值为80.00%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Lung cancer is the most prevalent malignancy globally, with prognosis and treatment largely influenced by histological and molecular analyses. Molecular features like PD-L1 positivity help identify patients suitable for immunotherapy. However, obtaining histological samples can be challenging and limited. Radiomic analysis of imaging data provides a non-invasive way to characterize tumor heterogeneity and its complex patterns, which may help predict PD-L1 expression. This study investigates the efficacy of radiomics in forecasting PD-L1 status in NSCLC patients using 18 F-FDG-PET/CT images. METHODS: In this retrospective study, the primary staging 18 F-FDG-PET/CT scans of 105 patients with NSCLC of different phenotypes (72 ACC, 33 SCC, 64 PD-L1 positive, 41 PD-L1 negative) were analysed. Various segmentation techniques were employed. Radiomic features were obtained from the original and transformed images using the PyRadiomics package. Records were split into training and test sets in the ratio of 7:3. Feature reduction involved the Mann-Whitney U test, LASSO regression, and Spearman correlation analysis. A logistic regression model was developed using the selected features, and performance was assessed with ROC curve, AUC score, and other metrics. RESULTS: The optimal model achieved an AUC of 0.783 (95% CI: 0.625, 942), with high accuracy (81.25%), sensitivity (90.00%), PPV (81.81%), and NPV (80.00%). CONCLUSION: Radiomic features derived from 18 F-FDG-PET/CT images can potentially differentiate between PD-L1 positive and negative NSCLC. Consequently, radiomics with multimodal imaging presents a promising non-invasive approach for selecting patients who may benefit from targeted immunotherapy.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Kiss FJ, Járó AI, Máthé D, et al. Predicting PD-L1 expression status in NSCLC using radiomic analysis of 18 F-FDG-PET/CT images. Eur J Nucl Med Mol Imaging. 2025. PMID: 40668270. doi:10.1007/s00259-025-07453-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。